Cancer and Leukemia Group B

癌症和白血病 B 组

• 批准号: 7276638
• 负责人: DAVID D HURD
• 金额: $ 24.8万
• 依托单位: WAKE FOREST UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 1979
• 资助国家: 美国
• 起止时间: 1979-04-01 至 2009-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7276638
• 关键词: Address; Applications Grants; Award; Back; Cancer Biology; Cancer Center; Cancer Patient; Cancer and Leukemia Group B; Caring; Chairperson; Cities; Clinical; Clinical Research; Clinical Research Protocols; Clinical Trials; Clinical Trials Cooperative Group; Comprehensive Cancer Center; Comprehensive Cancer Center of Wake Forest University; Conduct Clinical Trials; Conflict (Psychology); Data; Development; Disease; Drug Industry; Funding; Grant; Gynecologic Oncology; Health Sciences; Hematology; Leadership; Malignant Neoplasms; Medical Oncology; Medicine; Minority; Modality; Modification; NCI Center for Cancer Research; North Carolina; Patients; Pediatric Oncology; Population; Prevention; Protocols documentation; Public Health; Radiation Oncology; Recommendation; Research; Research Ethics Committees; Research Infrastructure; Research Personnel; Review Committee; Rome; Surgical Oncology; Universities; base; cancer research center director; data management; forest; improved; medical schools; member; oncology; organizational structure; programs; research study

DESCRIPTION (provided by applicant): This Ul0 application is in support of the CALGB Cooperative Group Clinical Trials conducted through the Wake Forest University School of Medicine (WFUSM) and its affiliate Members. WFUSM has been continuously awarded a CALGB U10 Grant for 45 years (CA03927) as the key support of the infrastructure for data management, the required administrative interactions with our Affiliate Members, and for the support of scientific and administrative contributions to CALGB. In addition to support for the Main Member, this U10 Grant supports the oversight of activity at our two current Affiliate Members, East Carolina University, Greenville, North Carolina and Carolina Oncology Associates of Salisbury, Salisbury, North Carolina. The specific aims of this grant application are: * To increase our scientific contributions to Disease and Modality Committee activities * To enhance the participation of our clinical research investigators through the development of pilot data at the Comprehensive Cancer Center of Wake Forest University that can be developed into CALGB protocols * To expand the Affiliate Network of the Comprehensive Cancer Center of Wake Forest University in order to provide improved care of the cancer patient through access to CALGB Cancer Clinical Trials * To provide a clinical trials mechanism by which minority populations can accrue to clinical trails; to improve their proportional participation in clinical trials research; and to develop specific strategies to address regional barriers to minority recruitment and retention in clinical research studies * To continue our participation as a funded Prevention Member Center

描述（由申请人提供）：此UL0申请支持通过Wake Forest大学医学院（WFUSM）及其会员成员进行的Calgb合作集团临床试验。 WFUSM已被连续授予45年的CALGB U10赠款（CA03927），作为数据管理基础架构，与我们的会员的所需管理互动的主要支持，并支持对Calgb的科学和行政贡献。除了支持主要成员外，这项U10赠款还支持我们目前的两个会员，东卡罗来纳州大学，格林维尔，北卡罗来纳州格林维尔和卡罗来纳州肿瘤学伙伴，北卡罗来纳州索尔兹伯里。该赠款申请的具体目的是： *增加我们对疾病和形态委员会活动的科学贡献 *通过在Wake Forest University综合癌症中心开发飞行员数据来增强我们的临床研究研究者的参与 *扩大维克森林大学综合癌症中心的会员网络，以通过获得CALGB癌症临床试验来改善对癌症患者的护理 *提供一种临床试验机制，少数人群可以在临床路上累积；提高他们对临床试验研究的比例参与；并制定特定策略来解决临床研究中少数族裔招募和保留率的区域障碍 *继续我们作为资助的预防会员中心的参与